Inhaled budesonide induced Cushing's syndrome in cystic fibrosis patients, due to drug inhibition of cytochrome P450 - PubMed (original) (raw)
Case Reports
Inhaled budesonide induced Cushing's syndrome in cystic fibrosis patients, due to drug inhibition of cytochrome P450
Elke De Wachter et al. J Cyst Fibros. 2003 Jun.
Free article
Abstract
Two CF patients developed Cushing's syndrome during administration of inhaled budesonide (400 microg/d) with oral itraconazole in one and with clarithromycin in the other patient. Clinical features appeared respectively after 2 and 6 weeks of drug co-administration, with prolonged adrenal suppression, and a slow recovery after ceasing the drugs. Inhibitors of the cytochrome P450 interfere with the metabolism of corticosteroids. Combination of these drugs even with moderate doses of budesonide should be closely monitored.
Similar articles
- [Adrenal cortex insufficiency after combination therapy with itraconazole and budesonide].
Skov M, Main KM, Sillesen IB, Müller JR, Koch C, Thorsteinsson SL. Skov M, et al. Ugeskr Laeger. 2003 May 19;165(21):2198-201. Ugeskr Laeger. 2003. PMID: 12820508 Danish. No abstract available. - Cushing's syndrome due to pharmacological interaction in a cystic fibrosis patient.
Main KM, Skov M, Sillesen IB, Dige-Petersen H, Müller J, Koch C, Lanng S. Main KM, et al. Acta Paediatr. 2002;91(9):1008-11. doi: 10.1080/080352502760272759. Acta Paediatr. 2002. PMID: 12412882 - Cushing's syndrome due to interaction between inhaled corticosteroids and itraconazole.
Bolland MJ, Bagg W, Thomas MG, Lucas JA, Ticehurst R, Black PN. Bolland MJ, et al. Ann Pharmacother. 2004 Jan;38(1):46-9. doi: 10.1345/aph.1D222. Ann Pharmacother. 2004. PMID: 14742792 - Adrenal suppression and Cushing's syndrome secondary to an interaction between ritonavir and fluticasone: a review of the literature.
Foisy MM, Yakiwchuk EM, Chiu I, Singh AE. Foisy MM, et al. HIV Med. 2008 Jul;9(6):389-96. doi: 10.1111/j.1468-1293.2008.00579.x. Epub 2008 May 4. HIV Med. 2008. PMID: 18459946 Review. - Inhaled medication and inhalation devices for lung disease in patients with cystic fibrosis: A European consensus.
Heijerman H, Westerman E, Conway S, Touw D, Döring G; consensus working group. Heijerman H, et al. J Cyst Fibros. 2009 Sep;8(5):295-315. doi: 10.1016/j.jcf.2009.04.005. Epub 2009 Jun 25. J Cyst Fibros. 2009. PMID: 19559658 Review.
Cited by
- Adrenal suppression: A practical guide to the screening and management of this under-recognized complication of inhaled corticosteroid therapy.
Ahmet A, Kim H, Spier S. Ahmet A, et al. Allergy Asthma Clin Immunol. 2011 Aug 25;7(1):13. doi: 10.1186/1710-1492-7-13. Allergy Asthma Clin Immunol. 2011. PMID: 21867553 Free PMC article. - A prospective evaluation on the interaction of fluconazole and voriconazole on serum concentrations of budesonide in patients treated for gastrointestinal GVHD.
Hughes TE, Stansfield L, Kumar P, Worthy T, Tian X, Childs RW. Hughes TE, et al. Bone Marrow Transplant. 2020 Jun;55(6):1085-1092. doi: 10.1038/s41409-020-0786-8. Epub 2020 Jan 17. Bone Marrow Transplant. 2020. PMID: 31953533 Free PMC article. - A critical role for vascular smooth muscle in acute glucocorticoid-induced hypertension.
Goodwin JE, Zhang J, Geller DS. Goodwin JE, et al. J Am Soc Nephrol. 2008 Jul;19(7):1291-9. doi: 10.1681/ASN.2007080911. Epub 2008 Apr 23. J Am Soc Nephrol. 2008. PMID: 18434569 Free PMC article. - Inhalational Steroids and Iatrogenic Cushing's Syndrome.
A V R. A V R. Open Respir Med J. 2014 Jan 31;8:74-84. doi: 10.2174/1874306401408010074. eCollection 2014. Open Respir Med J. 2014. PMID: 25674177 Free PMC article. - Drug interactions between inhaled corticosteroids and enzymatic inhibitors.
Daveluy A, Raignoux C, Miremont-Salamé G, Girodet PO, Moore N, Haramburu F, Molimard M. Daveluy A, et al. Eur J Clin Pharmacol. 2009 Jul;65(7):743-5. doi: 10.1007/s00228-009-0653-4. Epub 2009 Apr 28. Eur J Clin Pharmacol. 2009. PMID: 19399485 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical